Topical Scar Treatment Market To Reach $29.58 Billion By 2030

Topical Scar Treatment Market Growth & Trends

The global topical scar treatment market is expected to reach USD 29.58 billion by 2030, growing at a CAGR of 9.3% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of burn injuries, skin-related disorders, and trauma are major factors likely to contribute to market growth. Topical products are a variety of substances, compounds, or mixtures that are designed for application on the skin, hair, or nails, with a purpose to exert their effects specifically on the applied area. They are frequently incorporated into routines for personal care, including skincare and haircare.

Moreover, the market is likely to be driven by the growing acceptance of ambulatory surgery centers and introduction of portable or mobile devices for scar treatment in both developed and developing regions. The market has seen significant technological advancements, including the introduction of laser therapies such as the Q-switched laser-based device, MedLite C6, which is specifically designed for treating acne. These laser instruments assist in the breakdown of scar tissue, thereby simplifying scar treatment procedures.

A model was established by examining the occurrence of scars across different regions and countries. It was observed that most patients preferred topical treatments for managing their scars. The usage rates of creams, gels, silicon sheets, and other products were subsequently analyzed. Furthermore, factors such as the average pricing of products, their usability, and the duration of treatment were considered to estimate the market size and allocate the segment division for each type of product.

 Request a free sample copy or view report summary: Topical Scar Treatment Market Report

Topical Scar Treatment Market Report Highlights

• By product, creams dominated the market with a revenue share of 36.3% in 2023. Topical creams have specific vitamins and other skincare ingredients that help reduce a scar's appearance and is expected to positively impact the market growth

• By scar type, atrophic scars dominated the market and accounted for 37.1%. This type of scar looks like a pit and is typically caused by staphylococcus infections, acne, chickenpox, and surgery. As the demand for aesthetic appeal grows, the need for topical products to treat atrophic scars also increases

• By end-use, hospitals dominated the market and accounted for 42.1%. This is due to the usage of sophisticated infrastructure and the presence of technologically advanced products in these settings for scar treatment

• In 2023, North America dominated the market with a revenue share of 33.9%. The region's advanced healthcare infrastructure, high aesthetic consciousness among people, rapid adoption of advanced products, and a growing aging population contributes to the market's dominance

Topical Scar Treatment Market Segmentation

For this study, Grand View Research has segmented the global topical scar treatment market based on product, scar type, end-use, and region:

Topical Scar Treatment Product Outlook (Revenue, USD Million, 2018 - 2030)

• Creams

• Gels

• Silicon Sheets

• Others

Topical Scar Treatment Scar Type Outlook (Revenue, USD Million, 2018 - 2030)

• Atrophic Scars

• Hypertrophic & Keloid Scars

• Contracture Scars

• Stretch Marks

Topical Scar Treatment End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinics

• Homecare

Topical Scar Treatment Country Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • Spain

  • France

  • Italy

  • Russia

  • Denmark

  • Norway

  • Sweden

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Topical Scar Treatment Market

• Smith & Nephew PLC

• Lumenis

• Merz Pharmaceuticals, LLC

• Sonoma Pharmaceuticals, Inc.

• Cynosure

• CCA Industries, Inc.

• Newmedical Technology Inc.

• Mölnlycke Health Care AB

• Suneva Medical

• Scar Heal Inc.

• Pacific World Corporation

• Perrigo Company plc

• Enaltus LLC